Amoxicillin: Difference between revisions

To overcome the issue of [[β-lactamase]] production by resistant organisms, amoxicillin (in either trihydrate or sodium salt forms) may be combined with [[clavulanic acid]], typically as the [[potassium]] salt. This combination has activity against a very broad array of [[Gram-positive]], [[Gram-negative]], and [[anaerobic organisms]]. It is not active against [[MRSA]], ''[[P. aeruginosa]]'', or ''[[C. difficile]]''. It is available in oral preparations worldwide and also in the [[intravenous]] preparation in some countries. The [[British Approved Name]] for this formulation is [[co-amoxiclav]], but it is commonly referred to in practice by proprietary names such as '''AMK''', '''Amoksiklav''', '''Augmentin''', '''Clamoxyl''', '''Augclac''', '''Augmexx''', and '''Yucla''' depending on country.